Orliaguet Marie, Fong Shao Bing, Le Pottier Laëtitia, Meuric Vincent, Boisramé Sylvie, Bonnaure-Mallet Martine, Pers Jacques-Olivier
Univ Brest, CHU de Brest, Brest, France.
University of Rennes 1, Rennes, France.
Front Microbiol. 2023 Feb 8;14:1071683. doi: 10.3389/fmicb.2023.1071683. eCollection 2023.
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized by exocrine gland dysfunction. No therapeutic strategy is sufficient on its own for the management of dry mouth and therapeutic innovations are required.
This Predelfi study was a single-center, prospective, comparative, randomized, double-blind, cross-over controlled study with the primary objective of assessing the tolerance to and effectiveness of two adhesive biofilms (containing prebiotics and, sodium alginate, respectively) in patients with pSS and hyposialia (#NCT04206826 in ClinicalTrials.gov). Secondary objectives were to obtain initial data regarding the clinical effectiveness of such biofilms in the improvement of signs and symptoms related to dry mouth and potential changes in the oral microbiota. Ten pSS patients with pSS were included (9 females and 1 male) with a mean age of 58.1 ± 14.0 years.
Tolerance to the prebiotic and sodium alginate biofilms was assessed by the patients (visual analog scale [VAS] score 66.7 and 87.6, respectively) and the practitioner (90 and 100, respectively). The absolute changes in the VAS scores at the start and end of each treatment period highlighted an improvement in mouth dryness for the sodium alginate versus the prebiotic biofilm. The VAS scores for other parameters (mouth burning sensation; taste alteration; chewing; swallowing and speech difficulties) remained globally comparable between the two groups. Unstimulated salivary flow showed no changes regardless of the biofilm used. Regarding the oral microbiota, the sodium alginate biofilm increased the abundance of the genus, whereas the use of the prebiotic biofilm as the first treatment increased the abundance of the genera and . Nevertheless, the prebiotic biofilm appeared to stimulate "milder" genera with regard to periodontal infections. Furthermore, pre-treatment with the prebiotic biofilm prevented the emergence of the genus induced by subsequent treatment with the sodium alginate biofilm, suggesting a potential protective effect.
原发性干燥综合征(pSS)是一种以腺外分泌功能障碍为特征的全身性自身免疫性疾病。目前尚无单一的治疗策略足以有效管理口干症状,因此需要进行治疗创新。
这项Predelfi研究是一项单中心、前瞻性、比较性、随机、双盲、交叉对照研究,其主要目的是评估两种黏附性生物膜(分别含有益生元和海藻酸钠)对pSS和唾液分泌减少患者的耐受性和有效性(ClinicalTrials.gov上的#NCT04206826)。次要目的是获取关于此类生物膜改善口干相关体征和症状的临床有效性以及口腔微生物群潜在变化的初始数据。纳入了10例pSS患者(9例女性和1例男性),平均年龄为58.1±14.0岁。
患者(视觉模拟量表[VAS]评分分别为66.7和87.6)和医生(分别为90和100)评估了对益生元和海藻酸钠生物膜的耐受性。每个治疗期开始和结束时VAS评分的绝对变化突出显示,与益生元生物膜相比,海藻酸钠生物膜在改善口干方面效果更佳。两组在其他参数(口腔烧灼感、味觉改变、咀嚼、吞咽和言语困难)的VAS评分总体上相当。无论使用何种生物膜,非刺激性唾液流量均无变化。关于口腔微生物群,海藻酸钠生物膜增加了某属的丰度,而将益生元生物膜作为首次治疗则增加了另外两个属的丰度。然而,就牙周感染而言,益生元生物膜似乎刺激的是“较温和”的属。此外,用益生元生物膜进行预处理可防止后续使用海藻酸钠生物膜治疗诱导某属的出现,提示可能具有保护作用。